This study was conducted to detect the genes encoding extended-spectrum b-lactamases (ESBLs) and determine the epidemiological relatedness of 69 Escherichia coli and 33 Klebsiella pneumoniae isolates collected from a regional hospital in central Taiwan, mostly from inpatients (E. coli 87.0 %; K. pneumoniae 88.0 %). The phenotypes of these isolates were examined according to the combination disc method recommended by the Clinical and Laboratory Standards Institute. Most of the ESBL-producing E. coli and K. pneumoniae isolates (98.6 % and 97 %, respectively) could be detected using cefotaxime discs with and without clavulanate. Genotyping was performed by PCR with type-specific primers. CTX-M-14 type (53.6 %) was the most prevalent ESBL among E. coli isolates while SHV type (57.6 %) was the most dominant among K. pneumoniae isolates. Six E. coli and three K. pneumoniae isolates did not carry genes encoding ESBLs of types TEM, SHV, CTX-M-3, CTX-M-14, CMY-2 and DHA-1. The co-existence of two or more kinds of ESBL in a single isolate was common, occurring in 40.6 % and 72.7 % of E. coli and K. pneumoniae isolates, respectively. PFGE analysis revealed that ESBL producers isolated in this setting were genetically divergent.
INTRODUCTION
Since the first report in Germany in 1983 (Knothe et al., 1983) , the emergence of extended-spectrum b-lactamase (ESBL)-producing Klebsiella pneumoniae and Escherichia coli has become a serious problem in hospitalized patients worldwide (Hawser et al., 2009; Livermore et al., 2007; Paterson & Bonomo, 2005) . In Taiwan, the prevalence of ESBL producers has increased in recent years, ranging from 8.5 to 50.7 % in K. pneumoniae and 1.5 to 25.4 % in E. coli (Jean et al., 2009; Kuo et al., 2008; Yu et al., 2006) . According to Ambler's classification, ESBLs belong to the class A b-lactamases, which possess an active-site serine residue essential for the inactivation of b-lactam antimicrobial drugs (Ambler, 1980) . The term 'extendedspectrum b-lactamase' was originally applied to describe the TEM and SHV variants that can hydrolyse oxyiminocephalosporins (Paterson & Bonomo, 2005) . The 'extended spectrum' of activity is defined in terms of hydrolysing oxyimino-cephalosporins or aztreonam at more than 10 % of the activity of hydrolysing benzylpenicillin. Generally, ESBLs confer resistance to all penicillins, first-to-fourth generation cephalosporins and monobactams, but not to cephamycins or carbapenems. However, like many other class A b-lactamases, ESBLs are inactivated by the blactamase inhibitors, such as clavulanate (Bradford, 2001) . Most of the genes encoding ESBLs are plasmid-borne and are often located in the transposons and integrons (Eckert et al., 2006) , facilitating their mobilization with other resistance determinant. Thus the genes encoding ESBLs may be easily transferred between bacteria.
The most prevalent ESBLs are included in three groups: TEM, SHV and CTX-M. The SHV enzymes are named after the thiol variable active site and are commonly associated with K. pneumoniae. The TEM enzyme was named after the patient from which it was derived, Temoneira, and was first discovered in E. coli in Greece. A CTX-M-type ESBL, related to the chromosomal blactamase of Kluyvera ascorbata (Humeniuk et al., 2002) , was reported in 1989 and was characterized by a better hydrolysation of cefuroxime, cefotaxime and cefepime than that of ceftazidime (Bernard et al., 1992) . This type of ESBL has spread rapidly and is now one of the most dominant types of ESBLs in many countries Livermore et al., 2007) . At the time of writing, more than 120 SHV-type, 160 TEM-type and about 90 CTX-M-type ESBLs have been described (http://www.lahey.org/studies/ webt.asp).
AmpC, a typical class C enzyme, also confers resistance to oxyimino-cephalosporins if it is hyperproduced due to mutational depression (Livermore, 1987) or upon constitutive expression . The activity of class C enzymes is not inhibited by b-lactamase inhibitors, and thus AmpC is not traditionally considered a member of the ESBLs. However, some AmpC mutants, including CMY and DHA types, possess an extended-spectrum activity of b-lactamase and are also regarded as ESBLs (Barnaud et al., 1998; Bauernfeind et al., 1989; Wachino et al., 2006) .
OXA-type b-lactamase, belonging to functional group 2d of Bush's classification and class D in Ambler's scheme, has been reported mainly in Acinetobacter species and Pseudomonas aeruginosa (Naas & Nordmann, 1999) . Although most OXA b-lactamases have only negligible activity against oxyimino-cephalosporins, some OXA-type variants exhibit enhanced activity against oxyiminocephalosporins (Naas et al., 2008; Paterson & Bonomo, 2005) and are thus regarded as OXA-type ESBLs. In addition, a number of b-lactamases capable of hydrolysing extended-spectrum cephalosporins, including GES-1, VEB, PER, BEL, TLA, SFO and IBC, have already been reported in Gram-negative bacteria with less prevalence (Naas et al., 2008) .
This study describes the determination of the genes encoding ESBLs in E. coli and K. pneumoniae isolates collected from a regional hospital in central Taiwan from July 2005 to January 2006. The epidemiological relatedness of the isolates was also examined. This information would be useful for both understanding and preventing the spread of ESBL-producing E. coli and K. pneumoniae isolates. (CLSI, 2008) . Briefly, an ESBL producer was detected by using a disc containing ceftazidime (CAZ, 30 mg) or cefotaxime (CTX, 30 mg) in combination with and without clavulanate (CLA, 10 mg). The presence of an ESBL was determined by a ¢5 mm increase in zone diameters for CAZ/CLA and CTX/CLA compared with those for CAZ and CTX, respectively. The susceptibilities of the isolates to other drugs including amikacin, ampicillin/sulbactam, ampicillin, aztreonam, cefepime, ceftriaxone, cefazolin, gentamicin, imipenem, levofloxacin and sulfamethoxazole/trimethoprim were detected by the disc diffusion method. The reference strains were E. coli ATCC 25922 and K. pneumoniae ATCC 700603.
METHODS
PCR for the detection of genes encoding ESBLs. Detection of genes encoding ESBLs of types TEM, SHV, CTX-M-3, CTX-M-14, CMY-2 and DHA-1 was carried out by a PCR method using the primers listed in Table 1 , as described previously (Chia et al., 2005; Song et al., 2009) . Briefly, the 20 ml PCR mixture contained 10 mM Tris/HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 1 U Taq DNA polymerase, 0.2 mM deoxynucleoside triphosphate, 0.2 mM each primer and 1 ml DNA sample. The PCR was performed with 25 cycles of heat denaturation at 95 uC for 60 s, primer annealing at 48 uC for 60 s, and DNA extension at 72 uC for 70 s in a MyCycler thermal cycler (Bio-Rad). The amplified products were separated on a 1.5 % agarose gel, stained with ethidium bromide, and then visualized by UV transillumination.
Isoelectric focusing. Bacteria cultured in Mueller-Hinton broth for 20 h were centrifuged and the pellet was resuspended in 1 ml phosphate buffer (50 mM, pH 7.0). Cells were disrupted by sonication and subjected to isoelectric focusing in an ampholine gel (pH 3.0-10.0; Pharmacia). An isoelectric focusing broad pI calibration kit (pH 329; Pharmacia) was used to calculate the protein isoelectric point. b-Lactamases with known pI (TEM-1, pI 5.4; TEM-4, pI 5.9; SHV-2, pI 7.6; CTX-M-10, pI 8.1; and SHV-5, pI 8.2) were focused in parallel as controls. b-Lactamase activities were detected using filter paper containing 50 mg nitrocefin solution ml 21 (Oxoid).
PFGE analysis. Bacteria from an overnight culture grown on a brain heart infusion agar plate were washed and resuspended in cell suspension buffer (20 mM Tris/HCl, pH 8.0; 40 mM EDTA, pH 8.0). The final bacterial concentration was adjusted to an OD 600 of 1.6-1.8. About 10 ml 10 mg proteinase K ml 21 was added to 200 ml bacterial suspension, combined with 200 ml 1.0 % agarose, and then pipetted into small plug moulds. The plugs in 5 ml cell lysis buffer (50 mM Tris/HCl, pH 8.0; 50 mM EDTA, pH 8.0; 1 % N-lauroylsarcosine) were incubated at 56 uC for 2 h, then treated with TE buffer (10 mM Table 1 . Primers used in this study
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Tris/HCl, 100 mM EDTA) four times at 56 uC for 15 min. The DNA samples were digested with XbaI (Takara) (Tenover et al., 1995) and the resultant fragments were separated on a 1 % agarose gel using a CHEF-DR III system according to the manufacturer's instructions (Bio-Rad). The PFGE banding patterns were analysed using the BioNumerics version 4.61 software package (Applied Maths). One PFGE group was defined as containing at least three isolates with more than 75 % similarity.
RESULTS AND DISCUSSION
Phenotypic detection and antimicrobial susceptibility patterns ESBL producers were detected using CAZ (30 mg) or CTX (30 mg) discs with and without CLA (10 mg) according to CLSI guidelines. As shown in Table 2 , most of the E. coli and K. pneumoniae ESBL-producing isolates could be demonstrated using the combination of CTX and CTX/CLA. Only 1.4 % (isolate 14, data not shown) of E. coli and 3.0 % (isolate 57, data not shown) of K. pneumoniae ESBL producers were misidentified as non-ESBL producers by this combination. However, based on the genotypic analysis, E. coli isolate 14 carried the gene encoding CMY-2, while K. pneumoniae isolate 57 carried the SHV, TEM and CTX-M-14 genes (Tables 3 and 4 ). The phenotypic characterization of these two isolates did not reflect the genotype since the CMY-2 and CTX-M-14, and probably SHV and TEM, enzymes could generally hydrolyse CTX. Previously, certain difficulties in the detection of CTX-M type ESBLs were noted, especially when CAZ was used as the sole marker (Sabate et al., 2000) . In this study, we unexpectedly found that one isolate with a gene encoding a CTX-M-type ESBL could be detected using the CAZ and CAZ/CLA combination, but not by the CTX and CTX/CLA combination. This suggests that more than one kind of third-generation cephalosporin in combination with CLA would be needed for the detection of ESBL producers.
The antimicrobial susceptibility patterns of these isolates were also examined. These ESBL producers were found to be highly resistant to levofloxacin, sulfamethoxazole/ trimethoprim, ampicillin and all other examined blactams, except for cefepime and imipenem (Table 5) . Although some isolates were phenotypically susceptible to the broad-spectrum b-lactam antibiotics tested, they should be reported as resistant to avoid treatment failure. All examined E. coli isolates were susceptible to imipenem while one K. pneumoniae isolate was resistant to this agent. This implied that the imipenem-resistant K. pneumoniae isolate might produce carbapenemase or possess other imipenem-resistance determinants. A recent study also found that 2 % of ESBL-harbouring strains were resistant to imipenem (Lim et al., 2009) . The possible spread of imipenem-resistant ESBL producers should be noted in Taiwan in the future. The high ratio of co-resistance to quinolone, trimethoprim/sulfamethoxazole and aminoglycosides among ESBL producers collected from Taiwan has greatly limited the therapeutic role of these classes of antibiotics (Liao et al., 2006; Yu et al., 2004a) . With one exception, our findings corroborated the general rule that 11, 25, 31, 34, 45, 84, 109, 126, 52, 78, 88, 89, 93, 97, 103, 104, 105, 107, 111, 113, 116, 119, 120, 122, 127 26.1 CMY-2 14 1.4 TEM/CTX- 46, 62, 67, 71, 82, 40, 55, 61, 63, 64, 65, 68, 73 23, 47, 50, 56, 58, 90 8.7 imipenem is the drug of choice for the treatment of infections caused by ESBL producers.
Prevalence of ESBL genotypes in E. coli and K. pneumoniae isolates
Based on the PCR results, 8.7 %, 14.5 %, 26.1 % and 1.4 % of E. coli isolates possessed a single gene encoding a TEM, CTX-M-3, CTX-M-14 and CMY-2 type ESBL, respectively (Table 3) . Genes encoding ESBLs of types TEM, SHV, CTX-M-3, CTX-M-14, CMY-2 and DHA-1 were not found in a total of six isolates (8.7 %) ( Table 3 ). Isoelectric focusing analysis was then performed for the detection of b-lactamases among these isolates. The results revealed that isolate 23 possessed b-lactamases with pIs 5.4+8.3, isolates 50, 56, 58, and 90 possessed b-lactamases with pIs 4.5+8.3, and isolate 47 possessed b-lactamases with pIs 4.5+5.3+8.3 (data not shown). Thus, these six isolates might exhibit ESBLs, but were not readily detected by genotyping using the PCR method. It is possible that either a mutation occurred in the primer region or these blactamases did not belong to the ESBL types examined. The remaining E. coli isolates (40.6 %) carried more than one ESBL gene (Table 3 ). An earlier study in Taiwan showed that only 12.0 % of E. coli isolates harboured two or more ESBLs (Yan et al., 2006) . The increasing ratio of isolates with multiple ESBLs might reflect the spread of resistance determinants among ESBL producers or clonal expansion of certain multiple ESBL producers. Among E. coli isolates, CTX-M-14 and CMY-2 were the most prevalent ESBL (53.6 % of isolates) and AmpC (13.0 % of isolates) variants, respectively (Table 3) . Only one E. coli isolate was SHVpositive (isolate 115) and only one was DHA-1-positive (isolate 5). Previously, the most-frequent ESBL variant and plasmid-borne AmpC b-lactamase in E. coli reported in Taiwan were CTX-M and CMY-2, respectively (Yan et al., 2006) . The data also showed that 9.1 %, 6.1 % and 3.0 % of K. pneumoniae isolates possessed a single gene encoding TEM, CTX-M-3 and SHV type ESBLs, respectively (Table  4) . Three isolates (9.1 %) did not carry any genes encoding ESBLs of types TEM, SHV, CTX-M-3, CTX-M-14, CMY-2 and DHA-1. The remaining isolates (72.7 %) carried more than one ESBL gene, which was significantly higher than the previous report of 16.3 % (Yan et al., 2006) . SHV was the most prevalent ESBL type found (57.6 %) in K. pneumoniae isolates, while two AmpC variants, CMY-2 and DHA-1, had the same prevalence rate of 6.1 % (Table  4) . Previously, the most frequent ESBL and plasmid-borne AmpC b-lactamases in Taiwan were SHV and DHA-1-like in K. pneumoniae, respectively (Yan et al., 2006) . Our results shown in Tables 3 and 4 confirmed the previous findings. A recent study concerning healthcare-associated infection due to ESBL-producing E. coli or K. pneumoniae revealed that 24 % of ESBL-producing strains harboured multiple genes (Apisarnthanarak et al., 2008) . It was evident that the prevalence of isolates harbouring multiple ESBLs among our collection (Tables 3 and 4) was significantly higher than in previous reports. More recently, a study in north India found 57.4 % and 57.1 % of E. coli and K. pneumoniae isolates, respectively, possessing more than one ESBL (Goyal et al., 2009) . The high evolving prevalence of isolates with multiple ESBLs seems to be significant at least in some Asian regions.
PFGE pattern
The E. coli isolates were collected from urine (44/69, 63.8 %), surgical wounds (12/69, 17.4 %), blood (7/69, 10.1 %) and other samples including sputum, pleural effusion and catheter tip (6/69, 8.7 %). About half of the samples were obtained from females (55.1 %) and 87 % were from inpatients (data not shown). The K. pneumoniae isolates were collected from urine (20/33, 60.6 %), surgical wounds (3/33, 9.1 %), blood (2/33, 6.1 %) and other samples including sputum, pleural effusion, bile, ascitic fluid and catheter tip (8/33, 24.2 %). More than half of the samples were obtained from females (66.7 %) and 88 % were from inpatients (data not shown). The increasing prevalence of ESBL producers among K. pneumoniae and E. coli isolates may be caused by the dissemination of the resistance traits either by proliferation of epidemic strains or by transfer of resistance determinants (genes). To clarify this, the epidemiological relatedness of these clinical isolates was studied by PFGE. Based on PFGE pattern, 69 E. coli isolates were separated into 8 groups with 26 isolates unclassified (Fig. 1) . Thirty-three K. pneumoniae isolates were separated into 2 groups with 12 isolates unclassified (Fig. 2) . The results revealed that although mainly collected from inpatients, isolates in our collections were genetically divergent. Thus the gene encoding ESBL most likely had been disseminated via transfer of the resistance determinant among clinical isolates. Previously, ESBL-producing K. pneumoniae isolates collected from a district hospital in central Taiwan were also found to be genetically unrelated (Liu et al., 1998) . However, clonal dissemination of ESBLproducing K. pneumoniae isolates (both inter-hospital and intra-hospital dissemination) did occur among several regions in Taiwan (Yu et al., 2004b) .
Determination of ESBL type in ESBL-producing bacteria could provide useful epidemiology information. Since the phenotypic method and pI analysis cannot efficiently differentiate ESBL type, molecular techniques, such as PCR, are indispensable in detecting different ESBL genes. In this survey, the prevalent types of ESBL in E. coli and K. pneumoniae isolates correlated with those in previous studies in Taiwan; however, an increased number of isolates exhibiting multiple ESBLs were noted in our collection. PFGE analysis also demonstrated the possible horizontal spread of resistance determinants among these isolates. Although imipenem is still the drug of choice for ESBL-producer infections, possible imipenem resistance among ESBL producers in Taiwan should be noted in the future. 
